HIV vaccine, malaria control trials approved

KABANDA CHULU, Lusaka THE National Biosafety Authority (NBA) has approved two applications for HIV vaccine trials and malaria control sought by the Centre for Infectious Disease Research in Zambia (CIDRZ) and Macha Research Trust, respectively. The CIDRZ permit seeks to conduct research trials on the safety and immune-genicity of HVTN 120/ALVAC in Lusaka while the […]

Leave a Reply

Your email address will not be published. Required fields are marked *